Lin Jia

机构：Jilin University, VA Palo Alto Health Care System, First Hospital of Jilin University, Shenzhen Technology University · ORCID：0000-0002-5501-5029

发表论文 141 篇 · 总被引 4699 次 · h-index 36

代表论文

• The nano delivery systems and applications of mRNA (2021 · European Journal of Medicinal Chemistry · 被引 125)
• Lyophilization process optimization and molecular dynamics simulation of mRNA-LNPs for SARS-CoV-2 vaccine (2023 · npj Vaccines · 被引 71)
• Cationic liposomes co-deliver chemotherapeutics and siRNA for the treatment of breast cancer (2022 · European Journal of Medicinal Chemistry · 被引 53)
• Clinical Progress of PD-1/L1 Inhibitors in Breast Cancer Immunotherapy (2022 · Frontiers in Oncology · 被引 30)
• Sintilimab plus autologous NK cells as second-line treatment for advanced non-small-cell lung cancer previous treated with platinum-containing chemotherapy (2022 · Frontiers in Immunology · 被引 21)
• Manganese-Based Polyoxometalate Nanozyme-Metformin Co-functionalized Hydrogel Promotes Diabetic Wound Regeneration by Enhancing Phagocyte Efferocytosis (2025 · Research · 被引 13)